Lingjun Dong

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Low Density Lipoprotein

Circulating Tumor

Cell Proliferation

Ischemia Reperfusion Injury

Top Venues

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chuanqiang Wu, Bin Jiang, Zixiang Wu, Lingjun Dong, Keyi Sun, Ming Wu
LOX and Its Methylation Impact Prognosis of Diseases and Correlate with TAM Infiltration in ESCA. Journal of oncology 2022 (2022)
Lingjun Dong, Fuxiang Liang, Zhi-Ling Lou, Yangfan Li, Jinsheng Li, Yaling Chen, Jingjing Ding, Bin Jiang, Chuanqiang Wu, Huan Yu, Yafei Liu, Weiping Zhang, Yun-Bi Lu, Ming Wu
Necrostatin-1 Alleviates Lung Ischemia-Reperfusion Injury via Inhibiting Necroptosis and Apoptosis of Lung Epithelial Cells. Cells 11 (19) (2022)